Mabswitch CEO Dr. Onakunle will be presenting in the Antibody-Based Cancer Therapies track, discussing groundbreaking advancements in Remote Controlled Antibodies (TUE Nov 5th, 14:20). We’re proud to be part of this inspiring gathering, pushing forward the boundaries of cancer treatment.
Categories: Meetings
